These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 25785604)
21. p120-Catenin Downregulation and Kidacki M; Lehman HL; Green MV; Warrick JI; Stairs DB Mol Cancer Res; 2017 Oct; 15(10):1398-1409. PubMed ID: 28637905 [TBL] [Abstract][Full Text] [Related]
22. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. Lehman HL; Kidacki M; Stairs DB Sci Rep; 2020 Nov; 10(1):18829. PubMed ID: 33139779 [TBL] [Abstract][Full Text] [Related]
23. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma. Liu L; Yang Z; Ni W; Xuan Y Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036 [TBL] [Abstract][Full Text] [Related]
24. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis. Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075 [TBL] [Abstract][Full Text] [Related]
25. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma. Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734 [TBL] [Abstract][Full Text] [Related]
26. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma. Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma. Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946 [TBL] [Abstract][Full Text] [Related]
28. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients]. Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836 [No Abstract] [Full Text] [Related]
29. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis. Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434 [TBL] [Abstract][Full Text] [Related]
30. MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research. Chen X; Li X; Wang X; Zhu Q; Wu X; Wang X BMC Cancer; 2019 Feb; 19(1):171. PubMed ID: 30795761 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients. Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836 [TBL] [Abstract][Full Text] [Related]
32. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition. Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728 [TBL] [Abstract][Full Text] [Related]
33. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma. Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Chen FJ; Sun M; Li SQ; Wu QQ; Ji L; Liu ZL; Zhou GZ; Cao G; Jin L; Xie HW; Wang CM; Lv J; De W; Wu M; Cao XF Mol Carcinog; 2013 Nov; 52(11):908-15. PubMed ID: 24151120 [TBL] [Abstract][Full Text] [Related]
35. The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma. Zhu JL; Song YX; Wang ZN; Gao P; Wang MX; Dong YL; Xing CZ; Xu HM Histopathology; 2013 Jun; 62(7):1038-48. PubMed ID: 23614500 [TBL] [Abstract][Full Text] [Related]
36. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma. Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656 [TBL] [Abstract][Full Text] [Related]
37. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma. Kim R; Keam B; Kwon D; Ock CY; Kim M; Kim TM; Kim HJ; Jeon YK; Park IK; Kang CH; Kim DW; Kim YT; Heo DS World J Gastroenterol; 2016 Oct; 22(37):8389-8397. PubMed ID: 27729745 [TBL] [Abstract][Full Text] [Related]
38. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma. Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696 [TBL] [Abstract][Full Text] [Related]
39. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
40. Cigarette Smoke Mediates Nuclear to Cytoplasmic Trafficking of Transcriptional Inhibitor Kaiso through MUC1 and P120-Catenin. Zhang L; Gallup M; Zlock L; Feeling Chen YT; Finkbeiner WE; McNamara NA Am J Pathol; 2016 Dec; 186(12):3146-3159. PubMed ID: 27765636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]